Different gonadotrophin preparations derived from human urine or manufactured by recombinant technology are currently used in clinical practice for the treatment of infertility. It has been widely assumed that gonadotrophin products manufactured by recombinant technology have better batch-to-batch consistency compared with human-derived preparations and that this potentially will be shown to provide a more constant clinical response, but there is little evidence for either statement. This study compared the batch-to-batch consistency between urinary-derived and recombinant manufactured gonadotrophin preparations using standard analytical techniques, as well as a novel in-vitro follicle bioassay to evaluate the consistency of the biological response at the target organ. Oligosaccharide isoform profiling, immunoassay testing, size exclusion chromatography analysis and in-vitro bioassay testing of urinary derived gonadotrophin preparations (MENOPUR® and BRAVELLE®) confirm that these products display a high degree of batch-to-batch consistency, similar to recombinant FSH (GONAL-f®) either filled by mass or bioassay. The data also suggest that the batch-to-batch variation is independent of the manufacturing procedure (filled-by-bioassay of filled-by-mass) for the recombinant preparation (Gonal-f), but that the total FSH bioactivity delivered from a single dose preparation after reconstitution differs between the two manufacturing procedures.
|Título:||Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations|
|Autor:||Wolfenson, C.; Groisman, J.; Couto, A.S.; Hedenfalk, M.; Cortvrindt, R.G.; Smitz, J.E.J.; Jespersen, S.|
|Filiación:||Instituto Massone S.A. Arias 4431, 1430 Buenos Aires, Argentina|
CIHIDECAR, Faculty of Exact and Natural Science, University of Buenos Aires, Buenos Aires, Argentina
Ferring Pharmaceuticals A/S, Kay Fiskers Plads 11, 2300 Copenhagen S, Denmark
EggCentris NV, Kranenberg 6, 1731 Brussels, Belgium
|Palabras clave:||Batch-to-batch consistency; Gonadotrophin; Human-derived; In-vitro follicle bioassay; Recombinant FSH; chorionic gonadotropin; human menopausal gonadotropin; isoprotein; oligosaccharide; recombinant follitropin; urofollitropin; analytic method; article; clinical practice; drug design; drug determination; drug dosage form; drug manufacture; drug potentiation; drug quality; evidence based medicine; human; immunoassay; in vitro study; infertility; ovary follicle maturation; target organ; urine|
|Página de inicio:||442|
|Página de fin:||454|
|Título revista:||Reproductive BioMedicine Online|
|Título revista abreviado:||Reprod. BioMed. Online|
|CAS:||chorionic gonadotropin, 9002-61-3; human menopausal gonadotropin, 61489-71-2; recombinant follitropin, 1219693-73-8, 146479-72-3, 1359819-75-2; urofollitropin, 97048-13-0|
- Adriaens, I., Cortvrindt, R., Smitz, J., Differential FSH exposure in preantral follicle culture has marked effects on folliculogenesis and oocyte developmental competence (2004) Human Reproduction, 19, pp. 398-408
- Akar, A.H., Gervasi, G., Blacker, C., Human chronionic gonadotrophin-like and beta-core like materials in postmenopausal urine (1990) Journal of Endocrinology, 125, pp. 477-485
- Alfthan, H., Haglund, C., Dabek, J., Concentration of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and non-pregnant women (1992) Clinical Chemistry, 38, pp. 1981-1987
- Andersen, C.Y., Effect of FSH and its different isoforms on maturation of oocytes from pre-ovulatory follicles (2002) Reproductive BioMedicine Online, 5, pp. 232-239
- Andersen, C.Y., Westergaard, L.G., Wely, M.V., FSH isoform composition of commercial gonadotrophin preparations: A neglected aspect? (2004) Reproductive BioMedicine Online, 9, pp. 231-236
- Armstrong, E.G., Ehrlich, P.H., Birken, S., Use of a highly sensitive and a specific immunoradiometric assay for the detection of human chorionic gonadotropin in urine of normal, non-pregnant, and pregnant individuals (1984) Journal of Clinical Endocrinology and Metabolism, 59, pp. 867-874
- Babu, P.S., Krishnamurthy, H., Chedrese, P.J., Activation of extracellular-regulated kinase pathways in ovarian granulosa cells by the novel growth factor type 1 follicle-stimulating hormone receptor. Role in hormone signaling and cell proliferation (2000) Journal of Biological Chemistry, 275, pp. 27615-27626
- Baenziger, J.U., Green, E.D., Pituitary glycoprotein hormone oligosaccharides: Structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin (1988) Biochimica Et Biophysica Acta, 947, pp. 287-306
- Balasch, J., Fábregues, F., Peñarrubia, J., Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass (2004) Reproductive BioMedicine Online, 8, pp. 408-413
- Barrios-de-Timossi, J., Timossi, C., Merchant, H., Assessment of the in vitro and in vivo biological activities of the human follicle-stimulating isohormones (2002) Molecular and Cellular Endocrinology, 186, pp. 189-198
- Bishop, L., Nguyen, T., Schofield, P., Both of the beta-subunit carbohydrate residues of follicle-stimulating hormone determine the metabolic clearance rate and in vivo potency (1995) Endocrinology, 136, pp. 2635-2640
- Burgon, P., Stanton, P., Robertson, D., In vivo bioactivities and clearance patterns of highly purified human luteinizing hormone isoforms (1996) Endocrinology, 137, pp. 4827-4836
- Cortvrindt, R.G., Smitz, J.E.J., Follicle culture in reproductive toxicology: A tool for in-vitro testing of ovarian function? (2002) Human Reproduction Update, 8, pp. 243-254
- Cortvrindt, R.G., Hu, Y., Liu, J., Timed analysis of the nuclear maturation of oocytes in early preantral mouse follicle culture supplemented with recombinant gonadotropin (1998) Fertility and Sterility, 70, pp. 1114-1125
- Dahl, K.D., Bicsak, T.A., Hsueh, A.J.W., Naturally occurring antihormones: Secretion of FSH antagonists by women treated with a GnRH analog (1988) Science, 239, pp. 72-74
- Driebergen, R., Baer, G., Quantification of follicle stimulating hormone (follitropin alfa): Is in vivo bioassay still relevant in the recombinant age? (2003) Current Medical Research and Opinion, 19, pp. 41-46
- Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: A randomized, comparative trial (2002) Fertility and Sterility, 78, pp. 520-528. , EISG
- Gad, S.C., Weil, C.S., Statistics for toxicologists (1989) Principle and Methods of Toxicology, pp. 435-483. , Hayes AW (ed.) 2nd edn. Raven Press, New York
- Galway, A., Hsueh, A., Keene, J., In vitro and in vivo bioactivity of recombinant human follicle-stimulating hormone and partially deglycosylated variants secreted by transfected eukaryotic cell lines (1990) Endocrinology, 127, pp. 93-100
- Gervais, A., Hammel, Y.-A., Pelloux, S., Glycosylation of human gonatrophins: Characterization and batch-to-batch consistency (2003) Glycobiology, 13, pp. 179-189
- Green, E., Baenziger, J., Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. I. Structural elucidation of the sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones (1988) Journal of Biological Chemistry, 263, pp. 25-35
- Green, E., Baenziger, J., Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. II. Distributions of sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones (1988) Journal of Biological Chemistry, 263, pp. 36-44
- Horsman, G., Talbot, J.A., McLoughlin, J.D., A biological, immunological and physico-chemical comparison of the current clinical batches of the recombinant FSH preparations GONAL-f and Puregon (2000) Human Reproduction, 15, pp. 1898-1902
- Lambert, A., Rodgers, M., Mitchell, R., In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP (1995) Molecular Human Reproduction, 10, pp. 1928-1935
- McFarland, K., Sprengel, R., Phillips, H., Lutropin-choriogonadotropin receptor: An unusual member of the G protein-coupled receptor family (1989) Science, 245, pp. 494-499
- Mulders, J.W.M., Derksen, M., Swolfs, A., Prediction of the in vivo biological activity of human recombinant follicle stimulating hormone using quantitative isoelectric focusing (1997) Biologicals, 25, pp. 269-281
- Recombinant follicle stimulating hormone: Development of the first biotechnology product for the treatment of infertility (1998) Human Reproduction Update, 4, pp. 862-881. , Recombinant Human FSH Product Development Group
- Richards, J., Estradiol receptor content in rat granulosa cells during follicular development: Modification by estradiol and gonadotropins (1975) Endocrinology, 97, pp. 1174-1184
- Rose, M.P., Das, R.E.G., Balen, A.H., Definition and measurement of follicle stimulating hormone (2000) Endocrine Reviews, 21, pp. 5-22
- Sairam, M.R., Jiang, L.G., Yarney, T.A., Alternative splicing converts the G-protein coupled follitropin receptor gene into a growth factor type I receptor: Implications for pleiotropic actions of the hormone (1997) Molecular Reproduction and Development, 48, pp. 471-479
- Sasano, H., Okamoto, M., Mason, J., Immunolocalization of aromatase, 17 alpha-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary (1989) Journal of Reproduction and Fertility, 85, pp. 163-169
- Steelman, S.L., Pohley, F.M., Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotrophin (1953) Endocrinology, 53, pp. 604-614
- Tamura, T., Kitawaki, J., Yamamoto, T., Imunohistochemical localization of 17 alpha-hydroxylase/C17-20 lyase and aromatase cytochrome P450 in the human ovary during the menstrual cycle (1992) Journal of Endocrinology, 135, pp. 589-595
- Timossi, C., Dámian-Matsumura, P., Dominguez-González, R., A less acidic human follicle-stimulating hormone preparation induce tissue-type plasminogen activator enzyme activity earlier than a predominantly acidic analogue in phenobarbital-blocked pro-oestrous rats (1998) Molecular Human Reproduction, 4, pp. 1032-1038
- Timossi, C.M., Tomasib, J.B.D., Zambranob, E., A naturally occurring basically charged human follicle-stimulating hormone (FSH) variant inhibits FSH-induced androgen aromatization and tissue-type plasminogen activator enzyme activity in vitro (1998) Neuroendocrinology, 67, pp. 153-163
- Timossi, C.M., Barrios-de-Timossi, J., González-Suárez, R., Differential effect of the charge variants of human follicle-stimulating hormone (2000) Journal of Endocrinology, 165, pp. 193-205
- Vitt, U.A., Nayudu, P.L., Rose, U.M., Embryonic development after follicle culture is influenced by follicle-stimulating hormone isoelectric point range (2001) Biology of Reproduction, 65, pp. 1542-1547
- Westergaard, L.G., Erb, K., Laursen, S.B., Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: A prospective randomized study (2001) Fertility and Sterility, 76, pp. 543-549
- Wide, L., The regulation of metabolic clearance rate of human FSH in mice by variation of the molecular structure of the hormone (1986) Acta Endocrinologica, 112, pp. 336-344
- Wide, L., Hobson, B., Influence of the assay method used on the selection of the most active forms of FSH from the human pituitary (1986) Acta Endocrinologica, 113, pp. 17-22
---------- APA ----------Wolfenson, C., Groisman, J., Couto, A.S., Hedenfalk, M., Cortvrindt, R.G., Smitz, J.E.J. & Jespersen, S.
. Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations. Reproductive BioMedicine Online, 10(4), 442-454.
---------- CHICAGO ----------Wolfenson, C., Groisman, J., Couto, A.S., Hedenfalk, M., Cortvrindt, R.G., Smitz, J.E.J., et al.
"Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations"
. Reproductive BioMedicine Online 10, no. 4
(2005) : 442-454.
---------- MLA ----------Wolfenson, C., Groisman, J., Couto, A.S., Hedenfalk, M., Cortvrindt, R.G., Smitz, J.E.J., et al.
"Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations"
. Reproductive BioMedicine Online, vol. 10, no. 4, 2005, pp. 442-454.
---------- VANCOUVER ----------Wolfenson, C., Groisman, J., Couto, A.S., Hedenfalk, M., Cortvrindt, R.G., Smitz, J.E.J., et al. Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations. Reprod. BioMed. Online. 2005;10(4):442-454.